Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Journal of Internal Medicine|June 3, 2021
Increased long-term risk of heart failure and other adverse cardiac outcomes in dermatomyositis and polymyositis: Insights from a nationwide cohortA Yafasova, L P Diederichsen, M Schou, et al.
Diabetes, Obesity & Metabolism|May 16, 2014
Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide studyU M Mogensen, C Andersson, E L Fosbøl, et al.
Journal of Human Hypertension|June 6, 2008
Impact of the metabolic syndrome on the predictive values of new risk markers in the general populationM H Olsen, T W Hansen, M K Christensen, et al.
Clinical Pharmacology and Therapeutics|September 16, 2014
Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept studyK E Kristensen, H-J Zhu, X Wang, et al.
Journal of Clinical Epidemiology|May 1, 1994
Casual blood pressure in a general Danish population. Relation to age, sex, weight, height, diabetes, serum lipids and consumption of coffee, tobacco and alcoholM Kirchhoff, C Torp-Pedersen, K Hougaard, et al.
Journal of Human Hypertension|September 12, 2008
New risk markers may change the HeartScore risk classification significantly in one-fifth of the populationM H Olsen, T W Hansen, M K Christensen, et al.
Lancet (London, England)|May 23, 2000
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative GroupM D Flather, S Yusuf, L Køber, et al.
Heart (British Cardiac Society)|August 31, 2006
Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002P Buch, S Rasmussen, G H Gislason, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 24, 2018
Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort studyA C Ruwald, G H Gislason, M Vinther, et al.
The New England Journal of Medicine|December 21, 1995
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study GroupL Køber, C Torp-Pedersen, J E Carlsen, et al.
Pageof 15